...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum
【24h】

Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum

机译:通过在人血清中的二维同位素稀释LC-MS / MS方法同时定量七种重新灌注的Covid-19药物Remdesivir(Plus代谢GS-441524),氯喹,羟基喹啉,洛诺维尔,蓖麻养,FaviPiravir和氮杂霉素

获取原文
获取原文并翻译 | 示例

摘要

Background: The present COVID-19 pandemic has prompted worldwide repurposing of drugs. The aim of the present work was to develop and validate a two-dimensional isotope-dilution liquid chromatrography tandem mass spectrometry (ID-LC-MS/MS) method for accurate quantification of remdesivir and its active metabolite GS-441524, chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin in serum; drugs that have gained attention for repurposing in the treatment of COVID-19.
机译:背景:2019冠状病毒疾病流行促使世界范围内的药物重新使用。本研究的目的是开发和验证一种二维同位素稀释液相色谱-串联质谱(ID-LC-MS/MS)方法,用于准确定量血清中的雷米西韦及其活性代谢物GS-441524、氯喹、羟基氯喹、洛匹那韦、利托那韦、法维吡拉韦和阿奇霉素;C2019冠状病毒疾病治疗中应注意的药物。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号